Evidence map›Paper›PMID 22199353›Full record

ArticleThe Journal of biological chemistry2012

Dual regulation of notch1 signaling pathway by adaptor protein fe65.

Mi-Yeon Kim, Jung-Soon Mo, Eun-Jung Ann, Ji-Hye Yoon, Hee-Sae Park

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. FE65: a hub for neurodevelopment.Neural regeneration research · 2024
    Article
  3. Moving Breast Cancer Therapy up a Notch.Frontiers in oncology · 2018
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mi-Yeon KimHormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju 500-757, Republic of Korea.
Jung-Soon Mo
Eun-Jung Ann
Ji-Hye Yoon
Hee-Sae Park
Chonnam National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Notch1 receptor functions as a critical controller of cell fate decisions and also as a key regulator of cell growth, differentiation, and proliferation in invertebrates and vertebrates. In this study, we have demonstrated that the adaptor protein Fe65 attenuates Notch1 signaling via the accelerated degradation of the membrane-tethered Notch1 in the cytoplasm. Fe65 also suppresses Notch1 transcriptional activity via the dissociation of the Notch1-IC-recombining binding protein suppressor of hairless (RBP)-Jk complex within the nucleus. Fe65 is capable of forming a trimeric complex with Itch and membrane-tethered Notch1, and Fe65 enhances the protein degradation of membrane-tethered Notch1 via an Itch-dependent proteasomal pathway. Collectively, our results demonstrate that Fe65 carries out different functions depending on its location in the regulation of Notch1 signaling.

Indexed as

ProteolysisAnimalsCell NucleusCytoplasmHEK293 CellsHumansImmunoglobulin J Recombination Signal Sequence-Binding ProteinMiceNerve Tissue ProteinsNIH 3T3 CellsNuclear ProteinsProteasome Endopeptidase ComplexReceptor, Notch1Repressor ProteinsSignal TransductionUbiquitin-Protein LigasesAPBB1 protein, humanApbb1 protein, mouseImmunoglobulin J Recombination Signal Sequence-Binding ProteinITCH protein, humanItch protein, mouseNerve Tissue ProteinsNOTCH1 protein, humanNotch1 protein, mouseNuclear ProteinsProteasome Endopeptidase ComplexReceptor, Notch1Repressor ProteinsUbiquitin-Protein Ligases

Identifiers

PMID22199353
PMCPMC3281649
OpenAlexW2008233219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.